edoc

Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome

Hartung, H.-P. and Freedman, M. S. and Polman, C. H. and Edan, G. and Kappos, L. and Miller, D. H. and Montalbán, X. and Barkhof, F. and Petkau, J. and White, R. and Sahajpal, V. and Knappertz, V. and Beckmann, K. and Lanius, V. and Sandbrink, R. and Pohl, C. and Benefit Study Group, . (2011) Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome. Neurology, Vol. 77, H. 9. pp. 835-843.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6004556

Downloads: Statistics Overview

Abstract

To determine the frequency and consequences of neutralizing antibodies (NAbs) in patients with a first event suggestive of multiple sclerosis (MS) treated with interferon ?-1b (IFN?-1b).
Faculties and Departments:03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Neurologie > Neuroimmunologie (Kappos)
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Neurologie > Neuroimmunologie (Kappos)
UniBasel Contributors:Kappos, Ludwig
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:Lancet Publications
ISSN:0028-3878
Note:Publication type according to Uni Basel Research Database: Journal article
Identification Number:
Last Modified:06 Dec 2013 09:36
Deposited On:06 Dec 2013 09:36

Repository Staff Only: item control page